| Target Price | ¥2,244.00 |
| Price | ¥1,903.00 |
| Potential |
17.92%
register free of charge
|
| Number of Estimates | 3 |
|
3 Analysts have issued a price target Zeria Pharmaceutical 2027 .
The average Zeria Pharmaceutical target price is ¥2,244.00.
This is
17.92%
register free of charge
¥2,310.00
21.39%
register free of charge
¥2,222.00
16.76%
register free of charge
|
|
| A rating was issued by 7 analysts: 0 Analysts recommend Zeria Pharmaceutical to buy, 3 to hold and 4 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Zeria Pharmaceutical stock has an average upside potential 2027 of
17.92%
register free of charge
|
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 89.16 | 95.45 |
| 2.12% | 7.05% | |
| EBITDA Margin | 20.36% | 22.43% |
| 1.48% | 10.15% | |
| Net Margin | 9.48% | 10.16% |
| 16.68% | 7.14% |
2 Analysts have issued a sales forecast Zeria Pharmaceutical 2027 . The average Zeria Pharmaceutical sales estimate is
This results in the following potential growth metrics:
2 Zeria Pharmaceutical Analysts have issued a net profit forecast 2027. The average Zeria Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 191.80 | 219.98 |
| 14.91% | 14.69% | |
| P/E | 8.63 | |
| EV/Sales | 0.95 |
2 Analysts have issued a Zeria Pharmaceutical forecast for earnings per share. The average Zeria Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Zeria Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


